🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The brilliant light of our household has faded away for us in this life,” his family confirmed. “After a prolonged and courageous battle with the disease, we are heartbroken to announce that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his pioneering neo-soul sound and partnerships with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The album reached the fourth spot on the R&B charts, earned platinum status later that year, and received several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The album debuted at the top spot on each of the R&B charts and the Billboard 200. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction showed the singer, notably bare to his midsection, singing directly into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with a further No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public appearances in the subsequent period.

The singer was scheduled as a top act for the 2025 music event, but his performance was called off, due to an “unexpected health issue.”

Although information is limited about D’Angelo’s health in the weeks before his passing, he had apparently been hospitalized for months and in hospice for a fortnight.

D’Angelo’s demise is a stark reminder of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent types of the disease, on a gifted artist whose life was cut short.

“We are grieved that he can only provide cherished moments with his family, but we are eternally grateful for the legacy of extraordinarily moving music he leaves behind,” his family said.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic malignancy affects the pancreas, a small organ that produces the hormone insulin and plays an essential role in digestion, among other functions. The position and dimensions of the pancreas in the human system make it more difficult to detect malignancy.

Even though this cancer makes up only approximately three percent of cancer diagnoses annually in the United States, it is causes 7% of cancer deaths.

Almost 70,000 people will be diagnosed with pancreatic cancer and roughly 52,000 will succumb to the disease in 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and ineffective treatment options, and a narrow opportunity to make a significant difference on the lives of people,” noted a medical oncologist.

Because this disease rarely causes early symptoms, it’s often identified only once the disease is advanced. Even when a patient has symptoms they are usually nonspecific and may be mistaken for a number of common illnesses.

“Currently, there is no good way to detect this malignancy in the early stages, except for paying attention to physical changes and consulting your physician if there are new or unusual symptoms,” explained a medical director.

Common symptoms of pancreatic cancer include:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• loss of appetite
• dark urine
• light-colored or greasy stools
• diarrhea
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, many cancers, including this type, have become increasingly prevalent in younger people.

“This disease identified before the age of 50 is considered rare, yet alarmingly, doctors are beginning to see a growing number of younger patients suffering from this condition,” said a expert.

Genetic Background Impacts Disease Probability

Without effective detection methods for this malignancy, professionals emphasized the importance of understanding your family’s cancer history. Certain risk factors, such as smoking and obesity also have an influence in the onset of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are most likely to be found to have inoperable cancer.

“The first step toward lowering one’s chance of this condition is assessing individual susceptibility. Individuals should examine their family history, genetic background, and health issues, such as diabetes, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a specialist.

Inherited genetic elements are linked to as much as 10% of all this malignancy cases. If a relative in your family has had this disease, you may want to think about genetic testing.

“For individuals with a relative’s background of pancreatic cancer or those having high risk DNA changes, screening may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to detect initial alterations in the pancreas,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The best step you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a risk factor for this malignancy, so limiting or avoiding alcohol may help reduce your risk.

Controlling your weight or shedding pounds may also help decrease your susceptibility. Individuals with excess weight are 20% more likely to get this disease. Pancreatic cancer also is more frequent in those with diabetes, and reducing weight can also lower the chance of type 2 diabetes.

In spite of this disease’s grim outlook, there is reason for optimism.

“We are doing better with treatments and more recent combination chemotherapy. There are developing targeted therapies that are already showing results,” remarked a specialist.

For numerous people, however, awareness about this rare but {dev